Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Toxicology ; 212(2-3): 227-38, 2005 Sep 01.
Artigo em Inglês | MEDLINE | ID: mdl-15961209

RESUMO

Immature dendritic cells (DCs) derived from CD34+ progenitor cells or peripheral monocytes, are used as in vitro sensitization models in many chemical allergen treatment studies. During the sensitization, DCs follow maturation process and gain the capacity to migrate to lymph nodes where they stimulate T cells. Chemokine receptor allows DCs to migrate along chemotactic gradients. In this work, we used immature DCs from peripheral monocytes to evaluate the influence of allergens on chemokine receptor and surface-marker expression. We tested the sensitizers dinitrochlorobenzene, Bandrowski's base, and coumarin, as well as the tolerogen dichloronitrobenzene, the irritant sodium dodecyl sulfate and the solvent dimethyl sulfoxide. All skin sensitizers up-regulated the co-stimulatory molecule CD86 and increased the CD83+ cell population. No expression of the chemokine receptors CCR2, CCR3, CCR6, or CXCR5 was observed on DCs exposed to the tested chemicals. The strong allergen dinitrochlorobenzene slightly increased CCR7 expression on DCs but down-regulated CCR1 surface expression. CCR1 down-regulation was not mediated by a classical maturation pathway, as it was unaffected by the corticosteroid dexamethasone.


Assuntos
Alérgenos/farmacologia , Células Dendríticas/efeitos dos fármacos , Irritantes/farmacologia , Receptores de Quimiocinas/metabolismo , Antígenos CD/imunologia , Antígeno B7-1/imunologia , Antígeno B7-2 , Cumarínicos/farmacologia , Células Dendríticas/imunologia , Dimetil Sulfóxido/farmacologia , Dinitroclorobenzeno/farmacologia , Humanos , Imunoglobulinas/imunologia , Técnicas In Vitro , Leucócitos Mononucleares/citologia , Glicoproteínas de Membrana/imunologia , Fenilenodiaminas/farmacologia , Dodecilsulfato de Sódio/farmacologia , Antígeno CD83
2.
J Invest Dermatol ; 123(3): 494-502, 2004 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-15304089

RESUMO

After application of haptens on the skin, immature dendritic cells (DC), also named Langerhans cells (LC), migrate to the draining lymph node to sensitize naïve T-lymphocytes. Migration of DC involves many factors including the Cys-Cys chemokine receptor, CCR7. We investigated the effects of two well-known haptens, dinitrochlorobenzene (DNCB) and nickel (NiSO(4)), on the expression of CCR7 on human DC derived from CD34(+) progenitor cells. Both haptens were able to induce CCR7 expression and DC migration in response to Cys-Cys chemokine ligand, CCL19. Since interleukin (IL)-1beta and tumor necrosis factor (TNF)-alpha have been shown to participate in LC migration during contact hypersensitivity, we tested the effect of their neutralization on CCR7 expression. Neutralization of IL-1beta activity did not modify CCR7 expression in response to both haptens. CCR7 expression was strongly dependent on TNF-alpha in the case of DNCB, however, neutralization of TNF-alpha only partially reduced CCR7 expression upon NiSO(4) treatment. DNCB, NiSO(4) and TNF-alpha activated p38 mitogen-activated protein kinases (MAPK) and c-jun N-terminal kinase (JNK). Both p38 MAPK and JNK participated to TNF-alpha production induced by DNCB. Inhibition of both p38 MAPK and JNK affected significantly CCR7 expression upon nickel treatment whereas only inhibition of p38 MAPK but not of JNK downregulated CCR7 in the case of TNF-alpha stimulation. These results suggest that MAPK are necessary for haptens to induce CCR7 expression. NiSO(4), however, activates directly CCR7 expression through p38 MAPK and JNK activation whereas DNCB needs TNF-alpha whose secretion is also regulated by p38 MAPK and JNK.


Assuntos
Antineoplásicos/metabolismo , Células Dendríticas/efeitos dos fármacos , Irritantes/farmacologia , Níquel/farmacologia , Receptores de Quimiocinas/genética , Fator de Necrose Tumoral alfa/metabolismo , Antígenos CD34/metabolismo , Antineoplásicos/farmacologia , Quimiocina CCL19 , Quimiocinas CC/metabolismo , Quimiocinas CC/farmacologia , Células Dendríticas/fisiologia , Dinitroclorobenzeno/farmacologia , Regulação para Baixo , Feminino , Sangue Fetal , Haptenos/metabolismo , Humanos , Interleucina-1/metabolismo , Proteínas Quinases JNK Ativadas por Mitógeno , Sistema de Sinalização das MAP Quinases/efeitos dos fármacos , Sistema de Sinalização das MAP Quinases/fisiologia , Proteínas Quinases Ativadas por Mitógeno/antagonistas & inibidores , Proteínas Quinases Ativadas por Mitógeno/metabolismo , Fenótipo , RNA Mensageiro/análise , Receptores CCR7 , Fator de Necrose Tumoral alfa/farmacologia , Proteínas Quinases p38 Ativadas por Mitógeno
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA